Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

<div>SEM microscopy of nanoparticles: (a) empty nanoparticles; (b) nanoparticles containing enoxaparin.</div>

Journal of Nanotechnology

fig2

Figure 2

Figure 2: Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis 

Figure 2 | Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis 